Argonaute RNA company research projects build on existing intellectual property.
Argonaute RNA has raised $2.3M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in July 2024.
Argonaute RNA's investors include Development Bank of Wales, Empirical Ventures, The Fink Family Office, Bristol Private Equity Club.
Argonaute RNA is headquartered in Bristol, United Kingdom.
Argonaute RNA company research projects build on existing intellectual property.
Argonaute RNA is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Argonaute RNA — Funding & Investors." VCBacked, July 17, 2024, https://www.vcbacked.co/company/argonaute-rna. Accessed September 30, 2026.
VCBacked. (2024). Argonaute RNA — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/argonaute-rna
{{cite web |title=Argonaute RNA — Funding & Investors |url=https://www.vcbacked.co/company/argonaute-rna |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated